{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:08Z","timestamp":1707524888098},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,27]]},"DOI":"10.7759\/cureus.34275","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:52:43Z","timestamp":1674838363000},"source":"Crossref","is-referenced-by-count":0,"title":["Familial Primary Biliary Cholangitis With Different Clinical Courses Based on Anti-gp210 Antibody Positivity: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Takahiro","family":"Nagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310593","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'","volume":"64","author":"Beuers U","year":"2015","unstructured":"Beuers U, Gershwin ME, Gish RG, et al.. Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'. Gut. 2015, 64:1671-2. 10.1136\/gutjnl-2015-310593","journal-title":"Gut"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017, 67:145-72. 10.1016\/j.jhep.2017.03.022","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield GM","year":"2018","unstructured":"Hirschfield GM, Dyson JK, Alexander GJ, et al.. The British Society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018, 67:1568-94. 10.1136\/gutjnl-2017-315259","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor KD","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary biliary cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019, 69:394-419. 10.1002\/hep.30145","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30604","article-title":"Genome-wide association studies of specific antinuclear autoantibody subphenotypes in primary biliary cholangitis","volume":"70","author":"Wang C","year":"2019","unstructured":"Wang C, Zheng X, Jiang P, et al.. Genome-wide association studies of specific antinuclear autoantibody subphenotypes in primary biliary cholangitis. Hepatology. 2019, 70:294-307. 10.1002\/hep.30604","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2177\/jsci.28.117","article-title":"The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis (Article in Japanese)","volume":"28","author":"Nakamura M","year":"2005","unstructured":"Nakamura M. The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis (Article in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2005, 28:117-22. 10.2177\/jsci.28.117","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101916","article-title":"Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis","volume":"9","author":"Hu SL","year":"2014","unstructured":"Hu SL, Zhao FR, Hu Q, Chen WX. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis. PLoS One. 2014, 9:e101916. 10.1371\/journal.pone.0101916","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh S","year":"1998","unstructured":"Itoh S, Ichida T, Yoshida T, et al.. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 1998, 13:257-65. 10.1111\/j.1440-1746.1998.01553.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9121207","article-title":"Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis: a meta-analysis","volume":"2019","author":"Huang C","year":"2019","unstructured":"Huang C, Han W, Wang C, Liu Y, Chen Y, Duan Z. Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis: a meta-analysis. Dis Markers. 2019, 2019:9121207. 10.1155\/2019\/9121207","journal-title":"Dis Markers"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14688","article-title":"Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis","volume":"41","author":"Haldar D","year":"2021","unstructured":"Haldar D, Janmohamed A, Plant T, et al.. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver Int. 2021, 41:535-44. 10.1111\/liv.14688","journal-title":"Liver Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90084-o","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer PJ","year":"1991","unstructured":"Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991, 13:372-4. 10.1016\/0168-8278(91)90084-o","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig J","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978, 379:103-12. 10.1007\/BF00432479","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement","volume":"60","author":"Nakanuma Y","year":"2010","unstructured":"Nakanuma Y, Zen Y, Harada K, et al.. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010, 60:167-74. 10.1111\/j.1440-1827.2009.02500.x","journal-title":"Pathol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12270","article-title":"Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan","volume":"44","author":"Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis","year":"2014","unstructured":"Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan. Hepatol Res. 2014, 44:71-90. 10.1111\/hepr.12270","journal-title":"Hepatol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1999.0299","article-title":"Familial primary biliary cirrhosis in Hiroshima","volume":"13","author":"Tsuji K","year":"1999","unstructured":"Tsuji K, Watanabe Y, Van De Water J, et al.. Familial primary biliary cirrhosis in Hiroshima. J Autoimmun. 1999, 13:171-8. 10.1006\/jaut.1999.0299","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura M","year":"2005","unstructured":"Nakamura M, Shimizu-Yoshida Y, Takii Y, et al.. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol. 2005, 42:386-92. 10.1016\/j.jhep.2004.11.016","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20210501-00216","article-title":"Study of clinical characteristics in patients with gp210 antibody-positive primary biliary cholangitis (Article in Chinese)","volume":"30","author":"Huang CY","year":"2022","unstructured":"Huang CY, Liu YM, Liu H, et al.. Study of clinical characteristics in patients with gp210 antibody-positive primary biliary cholangitis (Article in Chinese). Zhonghua Gan Zang Bing Za Zhi. 2022, 30:419-25. 10.3760\/cma.j.cn501113-20210501-00216","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12210","article-title":"Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy","volume":"44","author":"Yoshioka Y","year":"2014","unstructured":"Yoshioka Y, Taniai M, Hashimoto E, Haruta I, Shiratori K. Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy. Hepatol Res. 2014, 44:947-55. 10.1111\/hepr.12210","journal-title":"Hepatol Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura M","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, et al.. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007, 45:118-27. 10.1002\/hep.21472","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2007.00244.x","article-title":"Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis","volume":"37","author":"Nakamura M","year":"2007","unstructured":"Nakamura M, Komori A, Ito M, et al.. Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol Res. 2007, 37:S412-9. 10.1111\/j.1872-034X.2007.00244.x","journal-title":"Hepatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135141-familial-primary-biliary-cholangitis-with-different-clinical-courses-based-on-anti-gp210-antibody-positivity-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:39Z","timestamp":1707508659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135141-familial-primary-biliary-cholangitis-with-different-clinical-courses-based-on-anti-gp210-antibody-positivity-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.34275","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,27]]}}}